81 FR 10862 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention Federal Register Volume 81, Issue 41 (March 2, 2016)
Centers for Disease Control and Prevention
Federal Register Volume 81, Issue 41 (March 2, 2016)
| Page Range | 10862-10862 | |
| FR Document | 2016-04591 |
[Federal Register Volume 81, Number 41 (Wednesday, March 2, 2016)] [Notices] [Page 10862] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-04591] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Childhood Obesity Research Demonstration 2.0, FOA DP 16-004, initial review. SUMMARY: This document corrects a notice that was published in the Federal Register on February 10, 2016, Volume 81, Number 27, pages 7123-7124. The meeting time and date should read as follows: Time and Date: 10:00 a.m.-6:00 p.m., EDT, March 15, 2016 (Closed). FOR FURTHER INFORMATION CONTACT: Jaya Raman, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F80, Atlanta, Georgia 30341, Telephone: (770) 488-6511, [email protected]. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2016-04591 Filed 3-1-16; 8:45 am] BILLING CODE 4163-18-P
![10862 Federal Register / Vol. 81, No. 41 / Wednesday, March 2, 2016 / Notices
Dated: February 25, 2016. announces the following committee the webcast can access information at:
Lorin S. Curit, meeting. http://cdclabtraining.adobeconnect.
Director, Federal Acquisition Policy Division, Times And Dates: 8:30 a.m.–5:00 com/aprilcliac/.
Office of Governmentwide Acquisition Policy, p.m., April 13, 2016; 8:30 a.m.–12:00 In-Person Attendance Online
Office of Acquisition Policy, Office of p.m., April 14, 2016. Registration Required: All people
Governmentwide Policy. Place: CDC, 1600 Clifton Road NE., attending the CLIAC meeting in-person
[FR Doc. 2016–04485 Filed 3–1–16; 8:45 am] Tom Harkin Global Communications are required to register for the meeting
BILLING CODE 6820–EP–P Center, Building 19, Auditorium B, online at least 5 business days in
Atlanta, Georgia 30333. advance for U.S. citizens and at least 10
Status: Open to the public, limited business days in advance for
only by the space available. The meeting international registrants. Register at:
DEPARTMENT OF HEALTH AND room accommodates approximately 100 http://www.cdc.gov/cliac/Meetings/
HUMAN SERVICES people. This meeting will also be MeetingDetails.aspx#.
webcast, please see information below. Register by scrolling down and
Centers for Disease Control and Purpose: This Committee is charged clicking the ‘‘Register for this Meeting’’
Prevention with providing scientific and technical button and completing all forms
advice and guidance to the Secretary of according to the instructions given.
Disease, Disability, and Injury Health and Human Services (HHS); the Please complete all the required fields
Prevention and Control Special Assistant Secretary for Health; the before submitting your registration and
Emphasis Panel (SEP): Initial Review Director, Centers for Disease Control submit no later than April 7, 2016 for
and Prevention; the Commissioner, U.S. registrants and March 31, 2016 for
The meeting announced below
Food and Drug Administration (FDA); international registrants.
concerns Childhood Obesity Research
and the Administrator, Centers for Providing Oral or Written Comments:
Demonstration 2.0, FOA DP 16–004,
Medicare and Medicaid Services (CMS). It is the policy of CLIAC to accept
initial review.
The advice and guidance pertain to written public comments and provide a
SUMMARY: This document corrects a general issues related to improvement in brief period for oral public comments on
notice that was published in the Federal clinical laboratory quality and agenda items whenever possible.
Register on February 10, 2016, Volume laboratory medicine practice and Oral Comments: In general, each
81, Number 27, pages 7123–7124. The specific questions related to possible individual or group requesting to make
meeting time and date should read as revision of the Clinical Laboratory oral comments will be limited to a total
follows: Improvement Amendment (CLIA) time of five minutes (unless otherwise
Time and Date: 10:00 a.m.–6:00 p.m., standards. Examples include providing indicated). Speakers must also submit
EDT, March 15, 2016 (Closed). guidance on studies designed to their comments in writing for inclusion
FOR FURTHER INFORMATION CONTACT: Jaya improve safety, effectiveness, efficiency, in the meeting’s Summary Report. To
Raman, Ph.D., Scientific Review Officer, timeliness, equity, and patient- assure adequate time is scheduled for
CDC, 4770 Buford Highway NE., centeredness of laboratory services; public comments, speakers should
Mailstop F80, Atlanta, Georgia 30341, revisions to the standards under which notify the contact person below at least
Telephone: (770) 488–6511, KVA5@ clinical laboratories are regulated; the one week prior to the meeting date.
cdc.gov. impact of proposed revisions to the Written Comments: For individuals or
The Director, Management Analysis standards on medical and laboratory groups unable to attend the meeting,
and Services Office, has been delegated practice; and the modification of the CLIAC accepts written comments until
the authority to sign Federal Register standards and provision of non- the date of the meeting (unless
notices pertaining to announcements of regulatory guidelines to accommodate otherwise stated). However, it is
meetings and other committee technological advances, such as new requested that comments be submitted
management activities, for both the test methods, the electronic at least one week prior to the meeting
Centers for Disease Control and transmission of laboratory information, date so that the comments may be made
Prevention and the Agency for Toxic and mechanisms to improve the available to the Committee for their
Substances and Disease Registry. integration of public health and clinical consideration and for public
laboratory practices. distribution. Written comments, one
Elaine L. Baker, Matters For Discussion: The agenda hard copy with original signature,
Director, Management Analysis and Services will include agency updates from CDC, should be provided to the contact
Office, Centers for Disease Control and CMS, and FDA. Presentations and person listed below, and will be
Prevention. discussions will include methods for included in the meeting’s Summary
[FR Doc. 2016–04591 Filed 3–1–16; 8:45 am] improving the effectiveness/efficiency Report.
BILLING CODE 4163–18–P of CLIAC meetings; an overview of the Availability of Meeting Materials: To
CMS Advisory Panel on Clinical support the green initiatives of the
Diagnostic Laboratory Tests; laboratory federal government, the CLIAC meeting
DEPARTMENT OF HEALTH AND interoperability including the Office of materials will be made available to the
HUMAN SERVICES the National Coordinator for Health Committee and the public in electronic
Centers for Disease Control and Information Technology (ONC) policies format (PDF) on the internet instead of
Prevention and engagement with clinical by printed copy. Check the CLIAC Web
mstockstill on DSK4VPTVN1PROD with NOTICES
laboratories; update on the cytology site on the day of the meeting for
Clinical Laboratory Improvement workload project; update on laboratory materials: http://wwwn.cdc.gov/cliac/
Advisory Committee biosafety in clinical laboratories; and cliac_meeting_all_documents.aspx.
future CLIAC topics. Note: If using a mobile device to access the
In accordance with section 10(a)(2) of Agenda items are subject to change as materials, please verify that the device’s
the Federal Advisory Committee Act priorities dictate. browser is able to download the files from
(Pub. L. 92–463), the Centers for Disease Webcast: The meeting will also be the CDC’s Web site before the meeting.
Control and Prevention (CDC) webcast. Persons interested in viewing Alternatively, the files can be downloaded to
VerDate Sep<11>2014 19:10 Mar 01, 2016 Jkt 238001 PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 E:\FR\FM\02MRN1.SGM 02MRN1](https://thefederalregister.org/doc/81_FR_10903/page/1.svg)
Document Created: 2018-02-02 15:04:27
Document Modified: 2018-02-02 15:04:27
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | 10:00 a.m.-6:00 p.m., EDT, March 15, 2016 (Closed). | |
| Contact | Jaya Raman, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F80, Atlanta, Georgia 30341, Telephone: (770) 488-6511, [email protected] | |
| FR Citation | 81 FR 10862 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR